Clinical Trials Directory

Trials / Terminated

TerminatedNCT04603963

Inspiratory Muscle Training in Patients With COVID-19

Efects of Inspiratory Muscle Training in Patients With COVID-19 After Acute Phase. Prospective Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Elaine Cristina Pereira <elaine.cpereira@einstein.br> · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

COVID 19 has become a pandemic and has led to high demand on healthcare systems. It can cause a severe acute respiratory syndrome (SARS CoV-2) which leads to a long hospital stay, developing important functional damage and making hospital discharge difficult. Elderly, obese and people with chronic diseases are more susceptible to contracting the disease, this profile of patients already has a predisposition for respiratory muscle weakness and in this context, after clinical stability, it is still necessary in a hospital environment to approach respiratory and motor physiotherapy. to optimize the recovery of these patients. Objective: Improved breathing, functionality, exercise capacity and muscle strength in non-critical patients. Method: Prospective randomized clinical study where one group received motor and respiratory physiotherapy and the other group performed the same therapy associated with inspiratory muscle training. Results: The findings will be compared before and after the approach and will be presented in graphs and tables. Statistical tests will be used considering a significance level of 5%.

Detailed description

Prospective clinical study in patients with COVID-19 admitted to a non-critical unit of a tertiary hospital. They were randomized into a group that received motor and respiratory exercises and another group that received the same exercises associated with respiratory muscle training.

Conditions

Interventions

TypeNameDescription
DEVICEpower breatherespiratory muscle training 1 time a day with power breathe 3 sets of 10 repetitions

Timeline

Start date
2020-06-01
Primary completion
2020-10-10
Completion
2020-10-23
First posted
2020-10-27
Last updated
2020-10-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04603963. Inclusion in this directory is not an endorsement.